Dr. Anne Chun-Hui Tsai is a professor and head of biochemical genetics at University of Illinois Chicago. She is board certified in pediatrics, medical genetics and genomics and Clinical biochemical genetics. Her clinical interests include inborn errors of metabolism, dysmorphology, clinical trial and fundamental biology。 She was a professor at University of Colorado and endowed chair at University of Oklahoma, where she was also the director of NORD COE. Dr. Tsai's research interests include rare diseases, neuroinflammation, and innovate treatment of IEM. She was involved in the development and clinical trials of GLP-2 and Myozyme.